According to the plaintiffs, these drugs caused them to develop pancreatic cancer, and they werent warned about the risk
FDA-approved GLP-1 receptor agonists include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda)
If patients receive GLP1 medications outside their primary health system (for example, from telehealth) or change providers during the treatment, the EHR data collected in our study may not capture the full course of treatment, and this may explain our observation of generally shorter treatment durations, and hence less weight loss, recorded in EHRs
Having said that, GSH-based medication has also been successfully employed to protect against cisplatin induced nephrotoxicity